1. Analysis of MRN-dependent and -independent topoisomerase removal mechanisms: implications for resistance against camptothecin and etoposide derivatives

   Hartsuiker, E. (PY)

   1/09/10 → 31/08/16

   Project: Ymchwil

2. Funding for equipment

   Hartsuiker, E. (PY)

   1/01/15 → 30/09/23

   Project: Ymchwil

3. Genome-wide analysis of topoisomerase removal after camptothecin treatment

   Hartsuiker, E. (PY)

   1/10/11 → 31/12/14

   Project: Ymchwil

4. Genome-wide analysis of topoisomerase removal pathways

   Hartsuiker, E. (PY)

   1/09/15 → 1/08/19

   Project: Ymchwil

5. Identification and analysis of DNA repair mechanisms that contribute to resistance against nucleoside analogues

   Hartsuiker, E. (PY)

   1/10/10 → 30/09/14

   Project: Ymchwil

6. KESS II MRes with NWCR - BUK2E091

   Hartsuiker, E. (PY)

   1/10/22 → 31/03/24

   Project: Ymchwil

7. KESS II MRes with North West Cancer Research BUK2222

   Hartsuiker, E. (PY)

   1/01/21 → 31/01/22

   Project: Ymchwil

8. KESS II MRes with North West Cancer Research BUK2224

   Hartsuiker, E. (PY)

   1/01/21 → 31/03/24

   Project: Ymchwil

9. KESS II MRes with North West Cancer Research- BUK2175

   Hartsuiker, E. (PY)

   1/10/18 → 1/08/22

   Project: Ymchwil

10. KESS II MRes with North West Cancer Research- BUK2176

    Hartsuiker, E. (PY)

    1/10/19 → 31/03/24

    Project: Ymchwil

11. KESS II MRes with North West Cancer Research- BUK2177

    Hartsuiker, E. (PY)

    1/10/18 → 31/03/24

    Project: Ymchwil

12. KESS II MRes with North West Cancer Research- BUK2178

    Hartsuiker, E. (PY)

    1/10/18 → 31/03/24

    Project: Ymchwil

13. KESS II Mres with NWCR in Molecular Medicine BUK2231

    Hartsuiker, E. (PY)

    1/10/22 → 31/03/24

    Project: Ymchwil

14. KESS II Phd with Tenovus BUK2E004

    Hartsuiker, E. (PY)

    1/03/20 → 31/03/24

    Project: Ymchwil

15. KESS II Phd with Tenovus Cancer Care Ltd- BUK2128

    Hartsuiker, E. (PY)

    1/11/17 → 31/03/24

    Project: Ymchwil

16. NWCR Research Fellow in Cancer Biology

    Hartsuiker, E. (PY)

    23/09/13 → 1/08/19

    Project: Ymchwil

17. Quantitative detection of DNA damage and nucleotides using LC/MS/MS

    Hartsuiker, E. (PY)

    1/01/16 → 30/04/16

    Project: Ymchwil

18. Role of DNA repair in resisting treatment with Gemcitabine and other analogues

    Hartsuiker, E. (PY)

    1/01/14 → 30/06/17

    Project: Ymchwil

19. Role of Mre11 nuclease activity in replication fork progression

    Hartsuiker, E. (PY)

    1/11/14 → 31/10/15

    Project: Ymchwil

20. Skills & Innovation voucher scheme - Beerobotics - Maxi

    Hartsuiker, E. (PY)

    1/05/24 → 28/02/25

    Project: Ymchwil

21. The NISCHR Cancer Genetics Biomedical Research Unit

    Hartsuiker, E. (PY)

    1/03/11 → 1/08/22

    Project: Ymchwil

22. The role of nucleotide excision repair in providing resistance to the nucleoside

    Hartsuiker, E. (PY)

    1/06/13 → 10/11/17

    Project: Ymchwil

23. The role of the Mre11 nuclease activity in resistance to cancer drugs

    Hartsuiker, E. (PY)

    1/12/11 → 30/11/13

    Project: Ymchwil

24. Wales Cancer Research Centre

    Hartsuiker, E. (PY)

    1/04/15 → 1/08/19

    Project: Ymchwil